The University of Chicago Header Logo

Connection

Tabraiz Mohammed to Maximum Tolerated Dose

Back to Details
This is a "connection" page, showing publications Tabraiz Mohammed has written about Maximum Tolerated Dose.
Tabraiz Mohammed
Connection Strength
0.027
Maximum Tolerated Dose
  1. A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer. Invest New Drugs. 2014 Apr; 32(2):295-302.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.